ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
1-Year Return
45.88%
This Quarter Return
+16.13%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$79.9M
AUM Growth
+$6.27M
(+8.5%)
Cap. Flow
-$3.65M
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
57.13%
Holding
44
New
13
Increased
11
Reduced
12
Closed
8
Top Buys
| 1 |
KALA BIO
KALA
|
$1.91M |
| 2 |
Pfizer
PFE
|
$1.89M |
| 3 |
Boston Scientific
BSX
|
$1.87M |
| 4 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$1.66M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$1.59M |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$6.28M |
| 2 |
Quest Diagnostics
DGX
|
$3.15M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
$2.32M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$2.06M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
$1.97M |
Sector Composition
| 1 | Healthcare | 95.27% |
